Can Microneedling Make Scars Worse? A Depth-by-Depth Guide to the Evidence

Yes, microneedling can make scars worse, but only under specific and largely preventable conditions. The published risk of true scar deterioration sits in the low single digits, roughly 1 to 5 percent of treated patients, and is concentrated in people with active acne, a history of keloids, darker Fitzpatrick skin types (IV to VI), or poor aftercare. Done at the correct depth, on the correct scar type, with the correct interval between sessions, microneedling improves scar appearance in the majority of treated cases. The outcome depends almost entirely on technique and patient selection, not on the device itself.

The two-directional mechanism: controlled injury versus uncontrolled injury

Microneedling works through a process called percutaneous collagen induction. Fine needles puncture the dermis to a set depth, typically 0.5 to 2.5 millimeters depending on the target, and the body responds by releasing platelet-derived growth factor and transforming growth factor beta. That cascade triggers new collagen and elastin deposition over 6 to 12 weeks. In scarred skin, the goal is to remodel disorganized collagen into a more normal lattice.

The same mechanism can run the wrong way. If needles penetrate too deep, are passed too many times, or are used on skin that is actively inflamed, the wound-healing response shifts toward excess fibroblast activity. Fibroblasts then lay down dense, parallel collagen instead of a basket-weave pattern. That is the cellular definition of a worse scar.

In plain terms: the treatment is a controlled wound, and a wound that is too large or too repetitive heals thicker, not smoother.

Depth is the single largest variable. Atrophic scars (indented, common in acne) improve with depths of 1.0 to 2.5 millimeters. Hypertrophic and keloid scars (raised) respond differently and carry far higher risk of worsening when needled aggressively. Melasma and post-inflammatory hyperpigmentation are pigment problems, not collagen problems, and needling them can darken the area rather than smooth it.

How often scars actually worsen: quantified risk by scar type

The risk is not uniform. It tracks tightly to scar morphology, skin tone, and technique.

These ranges come from pooled dermatologic case series rather than any single trial, so treat them as directional. A 2020 review of microneedling safety in dermatologic practice found transient side effects in most patients but persistent pigmentary or textural worsening in a small minority, consistent with the figures above. The pattern matters more than the exact percentage: keloid-prone skin is the highest-risk group by a wide margin.

The comparison most people miss is against doing nothing. Untreated atrophic acne scars improve on their own by roughly 10 to 20 percent over 12 months in younger patients. A well-executed microneedling course improves them by 40 to 60 percent in the same window. The margin is real but modest, which is why technique errors matter so much.

The recovery timeline and when "worse" is actually still healing

Most apparent worsening in the first two weeks is normal healing, not scar deterioration. This is the most common source of patient panic and the most common misread of the evidence. Distinguishing the two requires watching the clock.

A scar that looks angrier at day 10 is usually mid-remodeling. A scar that is measurably firmer and more raised at week 8 is a genuine adverse outcome and warrants stopping the course. The 6-to-12-week window is when collagen deposition peaks, and it is also when over-treatment becomes visible.

When microneedling is the wrong tool: edge cases and contraindications

Certain scars should not be needled at all, or only by a clinician with a different first-line plan.

• Active acne or any skin infection in the treatment area, since needling seeds inflammation deeper.
• A personal or family history of keloids, because the risk of a new keloid forming in the puncture field is substantial.
• Isotretinoin use within the prior 6 months, per long-standing dermatologic caution, though this rule is increasingly debated.
• Blood thinners or bleeding disorders, which raise bruising and hematoma risk.
• Immunosuppression or poorly controlled diabetes, which impairs wound healing.
• Active eczema, psoriasis, or rosacea in the zone, where the barrier is already compromised.

Keloids deserve a special note. Some clinicians do use microneedling to deliver steroid or 5-fluorouracil directly into a keloid, a technique called microneedling-assisted drug delivery. That is a controlled, clinician-directed procedure. At-home needling of a keloid is a different act with a different risk profile and should be avoided.

Professional caveat that cuts against the marketing: radiofrequency microneedling, which adds heat, carries a higher risk of post-inflammatory hyperpigmentation in darker skin than plain microneedling does. The added energy improves collagen output but raises the pigment cost, especially at depths above 2 millimeters in Fitzpatrick type V and VI skin.

The device and technique variables that decide the outcome

Two people can needle the same scar and get opposite results. The difference lives in four variables.

Needle depth relative to scar thickness is first. Needling shallower than the scar's own depth does little; needling far deeper than needed adds injury without benefit. A 1.0-millimeter atrophic scar does not need a 2.5-millimeter pass.

Passes per session are second. Most protocols use 4 to 6 passes in a single direction pattern, with a maximum of about 8 to 10 total passes. Beyond that, the collagen response plateaus while the inflammation curve keeps climbing.

Interval between sessions is third. The standard is every 4 to 6 weeks, and a full course runs 3 to 6 sessions. Retreatment before 4 weeks interrupts remodeling and stacks injury on injury, which is a direct route to a thicker scar.

Hygiene and aftercare are fourth. Reused or dulled needles, ungloved technique, and skipping sun protection each raise risk. UV exposure in the 4 weeks after a session is one of the most reliable ways to convert a good result into a pigmented one.

Device class matters less than users assume. A 2021 comparison of dermaroller and automated pen devices found similar clinical improvement when depth was matched, though pens gave more consistent depth control. The operator's judgment outweighs the brand.

Correcting the biggest misconceptions

Misconception one: deeper is always better. Depth should match scar thickness and skin region, not a fixed number. Facial skin is thinner than cheek skin, which is thinner than scar tissue on the back. Uniform deep passes across all of these cause harm.

Misconception two: at-home rollers are equivalent to clinical treatment. Home rollers typically reach 0.2 to 0.5 millimeters, which is superficial and rarely reaches scar depth. That makes them lower risk for scarring but also largely ineffective for real scars. The exception is that a home roller used too aggressively on thin skin can still cause pigment change.

Misconception three: any worsening means the treatment failed permanently. Most transient worsening resolves within 3 to 6 months once needling stops. Permanent textural worsening is uncommon and is usually tied to keloid formation or repeated over-treatment.

Misconception four, the non-obvious one: microneedling on a fresh surgical scar can be counterproductive. Immature scars under 6 to 8 weeks old are still actively remodeling on their own, and adding needle injury can push that process toward hypertrophy. The better window is after the scar has matured, typically 3 to 6 months post-injury, when remodeling has stabilized enough to be redirected.

In plain terms: timing relative to the scar's own life cycle matters as much as the depth of the needle.

What to actually do to minimize the risk of a worse scar

Concrete actions, in order of impact.

Screen yourself honestly. If you have a keloid history, active acne, or Fitzpatrick type V to VI skin, get a dermatologist's assessment before any needling, professional or at-home.

Choose a clinician over a device for anything deeper than 0.5 millimeters. Depth control and scar-type judgment are the two skills that separate safe from risky.

Respect the 4-to-6-week interval and cap the course at 3 to 6 sessions. More sessions at closer intervals increase risk without increasing benefit.

Protect the treated area from UV for at least 4 weeks after each session, with sunscreen of SPF 30 or higher and physical coverage.

Treat active acne first. Needling over active lesions is one of the clearest pathways to new or worsened scarring.

Stop and reassess if the scar is firmer and more raised at week 8. That is the signal to pause, not to push through a scheduled session.

Limits of the evidence and what remains uncertain

The honest position is that high-quality, long-term randomized trials on microneedling for scars are scarce. Most evidence comes from small comparative studies and case series with follow-up rarely exceeding 6 to 12 months. That means the long-term behavior of a remodeled scar beyond a year is not well characterized.

Several questions remain open. The exact threshold at which passes per session tip from benefit to harm is not standardized. Optimal depth by scar subtype is consensus-based rather than trial-proven. The isotretinoin waiting period is a tradition more than a finding. And keloid risk in predisposed patients is real but its magnitude is imprecise.

What is well supported: microneedling improves most atrophic scars when done at appropriate depth and interval, and it can worsen scars when done on the wrong scar type, too deep, too often, or without sun protection. The decision is less about whether the tool works and more about whether the specific scar and the specific skin are the right candidates for it.